AMCP 2022: Katie Lockhart of Magellan Health Talks the Financial Impact of Specialty Drugs & Cost-Impact Models
Katie Lockhart, MA, manager of Magellan Health, addresses her AMCP 2022 conference session on the financial impact of specialty drugs and cost-impact models.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
